Treating rheumatoid arthritis to an imaging target produces better outcomes, or does it?
Rheumatology (Oxford)
.
2021 Jan 5;60(1):3-4.
doi: 10.1093/rheumatology/keaa659.
Authors
Kulveer Mankia
1
,
Hanna Gul
1
,
Paul Emery
1
Affiliation
1
Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds NIHR Biomedical Research Centre, Leeds, UK.
PMID:
33175981
DOI:
10.1093/rheumatology/keaa659
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / diagnostic imaging
Arthritis, Rheumatoid* / drug therapy
Humans
Substances
Antirheumatic Agents